The Cigna Group reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health ...

Cigna (CI) reported better-than-expected Q4 2025 financials on Thursday, even as the managed care firm set its full-year ...

Feb 4 (Reuters) - Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing ...

Operating efficiency was another area of relative strength. Cigna’s SG&A expense ratio fell to 5.3% for full-year 2025, down ...

Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — ...

Cigna health insurance customers need to be aware of ongoing dispute. They are now out of network with Commonspirit, or ...

Cigna’s Q4 2025 financials were better than expected, even as the company lowered its full-year earnings guidance despite an ...

Cigna unveiled a new effort that aims to expand insurance coverage for weight loss drugs by limiting how much health plans and employers spend on highly popular weight loss drugs each year. Cigna's ...

Cigna remains a 'Hold' due to valuation concerns and systemic US healthcare risks despite recent sector underperformance.

On Dec. 31, 2025, an agreement was reached with Cigna on a new contract. As a result, the partnership between the two ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.